Search The Defender
Search Results for "Pfizer"
05/27/22Young Boy Died of Myocarditis After Pfizer Vaccine, Says CDC Before Signing Off on 3rd Shot for Kids 5-11
VAERS data released Friday by the Centers for Disease Control and Prevention show 1,277,980 reports of adverse events from all age groups following COVID-19 vaccines, including 28,312 deaths and 232,694 serious injuries between Dec. 14, 2020, and May 20, 2022.
05/23/22FDA Panel Sets June 15 Meeting on Pfizer, Moderna COVID Vaccines for Infants and Toddlers + More
The Defender’s COVID NewsWatch provides a roundup of the latest headlines related to the SARS CoV-2 virus, including its origins and COVID vaccines.
05/20/22Stephen Colbert, COVID and Pfizer’s Paxlovid Pill: Kim Iversen Weighs In
The Hill’s Kim Iversen this week weighed in on reports of people, including “The Late Show” host Stephen Colbert, experiencing “rebound” cases of COVID-19 after completing a course of Pfizer’s antiviral pill, Paxlovid.
05/19/22CDC Advisory Panel Approves 3rd Dose of Pfizer’s COVID-19 Vaccine for Kids 5-11
The Centers for Disease Control and Prevention’s independent vaccine advisory panel today endorsed the use of a third Pfizer COVID-19 vaccine for children ages 5 – 11, two days after the U.S. Food and Drug Administration granted Emergency Use Authorization for the booster.
05/18/22Pfizer Document Dump Shows Doctor With Ties to Gates Foundation Deleted Trial Participant’s Vaccine Injury
An 80,000-page cache of Pfizer-BioNTech COVID-19 vaccine documents released by the U.S. Food and Drug Administration sheds light on Pfizer’s extensive vaccine trials in Argentina, including the unusually large size of the trials and the story of a trial participant whose vaccine reaction was deleted.
05/17/22FDA Authorizes Pfizer Booster for Kids 5 to 11, Bypasses Advisory Panel
The U.S. Food and Drug Administration today granted Emergency Use Authorization for Pfizer’s COVID-19 booster for children ages 5 to 11, without convening its vaccine advisory panel and despite the latest data showing higher case rates in vaccinated children compared with those not vaccinated.
05/17/22FDA Dumps More Pfizer Documents: Why Were So Many Adverse Events Reported as ‘Unrelated’ to Vaccine?
The latest release by the U.S. Food and Drug Administration of Pfizer-BioNTech COVID-19 vaccine documents raises questions about how frequently adverse events experienced by clinical trial participants were reported as “unrelated” to the vaccine.
05/13/22Pfizer Booster Protection Against Omicron Wanes in Just Weeks, Study Finds
Second and third doses of Pfizer’s COVID-19 vaccine provide protection against the Omicron variant for only a few weeks, according to peer-reviewed research published today in JAMA Network Open.
05/13/22CHD Appeals Dismissal of Lawsuit Against FDA for ‘Deceptive’ Approval of Pfizer’s Comirnaty Vaccine
The District Court should not have dismissed a lawsuit filed last year by Children’s Health Defense against the U.S. Food and Drug Administration alleging the agency’s licensure of Pfizer’s Comirnaty COVID-19 vaccine was deceptive and rushed, CHD argued last week in its brief.
05/06/22FDA Limits Use of J&J Vaccine Over Blood Clotting Disorder, But Experts Say Pfizer, Moderna Shots Pose Similar Risk
The U.S. Food and Drug Administration on Thursday put strict limits on the use of Johnson & Johnson’s COVID-19 vaccine, citing the risk of a blood clotting condition, but experts say that Pfizer and Moderna pose similar risks.
05/05/22NIH Investigating Why Patients Relapse After Taking Pfizer’s COVID Antiviral Pill, Paxlovid
Responding to reports of patients relapsing after completing a five-day course of Paxlovid, Pfizer CEO Albert Bourla suggested patients just take more, prompting a rebuke from a U.S. Food and Drug Administration official.
05/03/22Pfizer Hopes to Submit Little-Kid Vaccine Data by Early June + More
The Defender’s COVID NewsWatch provides a roundup of the latest headlines related to the SARS CoV-2 virus, including its origins and COVID vaccines.
05/02/22What Pfizer, J&J COVID Vaccine Animal Trials Reveal About Shots’ Potential Impact on Major Organs
Judicial Watch today said documents obtained from the U.S. Department of Health and Human Services show lipid nanoparticles from Pfizer’s COVID-19 vaccine were found in the liver, ovaries and other organs 48 hours after injection, and Johnson & Johnson vaccine particles were present in test animals months after injection.
04/28/22Pfizer Tests Lyme Disease Vaccine on Kids, But Experts Question Need
Pfizer on Tuesday said results of Phase 2 clinical trials of its experimental Lyme disease vaccine delivered “positive” results, including among pediatric trial participants. The vaccine “offers Pfizer the chance to add a growth driver to its mammoth vaccine unit,” but some experts say treatment is a better solution.
04/27/22Lawmakers Push FDA on COVID Shots for Infants and Toddlers, Pfizer Asks FDA to Authorize Third Shot for Kids 5 to 11
In a letter to the U.S. Food and Drug Administration, members of the House coronavirus committee asked for a briefing on the status of COVID-19 vaccines for infants and children 6 months to 5 years, claiming “millions of young children still remain unprotected because no vaccine has yet been authorized” for this age group.
04/15/22Pfizer Knew Vaccine Injuries Were More Severe in People Under 55, Documents Reveal
Documents released April 1 by the U.S. Food and Drug Administration show the adverse event rate per dose for Pfizer’s mRNA jab, based on the company’s own studies, is nearly 1 in 800, and the myocarditis rate is 10 in 100,000 — far greater than the 2 in 100,000 rate previously reported.
04/14/22Pfizer to Ask FDA to Allow 3rd COVID Shot for Healthy 5- to 11-Year-Olds, Based on Study of 140 Kids
Pfizer and BioNTech today said they plan to apply for Emergency Use Authorization of a COVID-19 booster dose for healthy 5- to 11-year-olds based on results of a small study that has not been published or analyzed by independent experts.
04/06/22Exclusive: 34-Year-Old Died After Pfizer Shot, Mother Shares ‘Ridiculous’ Letters From CDC
In an exclusive interview with The Defender, Henrietta Simoes said her healthy, 34-year-old son, Victor Simoes, died suddenly two weeks after his first Pfizer COVID-19 shot. The Centers for Disease Control and Prevention, which is not investigating the death, responded with two “ridiculous” letters.
04/06/22‘Natural Immunity Works and Pfizer Knows It,’ FDA Document Dump Reveals
On The Hill’s “Rising,” journalist and political commentator Kim Iversen shared revelations from the latest batch of Pfizer COVID-19 vaccine documents, released April 1 by the U.S. Food and Drug Administration.
04/05/22Pfizer Hired 600+ People to Process Vaccine Injury Reports, Documents Reveal
Pfizer hired about 600 additional full-time employees to process adverse event reports during the three months following authorization of its COVID-19 vaccine, with plans to hire 1,800 more by June 2021, newly released documents reveal.
04/01/2217-Year-Old Died ‘Suddenly in Sleep’ 6 Months After 2nd Pfizer Shot
VAERS data released Friday by the Centers for Disease Control and Prevention included a total of 1,205,755 reports of adverse events from all age groups following COVID vaccines, including 26,396 deaths and 214,521 serious injuries between Dec. 14, 2020, and March 25, 2022.
03/31/22Pfizer Shot for Teens Less Effective Against Omicron, Study Shows
Pfizer’s COVID-19 vaccines showed “reduced effectiveness” against the Omicron variant among children 12 and older, according to a study published Wednesday in The New England Journal of Medicine.
03/31/22La inyección de Pfizer para los adolescentes es menos eficaz contra Omicron, según un estudio
Las vacunas COVID-19 de Pfizer mostraron una “eficacia reducida” contra la variante Omicron entre los chicos de 12 años o más, según un estudio publicado el miércoles en “The New England Journal of Medicine”.
03/29/22Heart Damage Found in Teens Months After Second Pfizer Shot, Study Shows
A new peer-reviewed study shows more than two-thirds of adolescents with COVID-19 vaccine-related myopericarditis had persistent heart abnormalities months after their initial diagnosis, raising concerns for potential long-term effects and contradicting claims by health officials that the condition is “mild.”
03/29/22Why Didn’t Pfizer, Moderna Have to Meet All FDA Criteria for EUA Products?
The U.S. Food and Drug Administration sets the criteria vaccine makers are supposed to meet in order to obtain Emergency Use Authorization for their products. So why didn’t Pfizer and Moderna have to meet all of those criteria?
03/29/22FDA Authorizes Fourth Pfizer and Moderna COVID Vaccine Doses for 50 and Older + More
The Defender’s COVID NewsWatch provides a roundup of the latest headlines related to the SARS CoV-2 virus, including its origins and COVID vaccines.
03/28/22Exclusive Interview: Woman Dies From Rare Brain Disorder After Second Pfizer Shot, Husband Says We’re ‘Guinea Pigs’
In an exclusive interview with The Defender, Richard Sprague said his wife, Jennifer, developed Creutzfeldt-Jakob Disease after the Pfizer COVID-19 shot and died within five months of the second dose.
03/25/22In Lab Study, Pfizer Vaccine Showed Potential to Alter DNA in Human Liver Cells, But Scientists Caution More Research Needed
Swedish researchers showed the mRNA from the Pfizer COVID-19 vaccine can be reverse-transcribed into DNA in human liver cells in vitro, but more research is needed to determine if this transcribed vaccine-derived DNA can integrate into human genomic DNA.
03/22/22Pfizer COVID Vaccine for Kids 5 – 11 Fails FDA Standard for 50% Efficacy
Based on a small study, the Centers for Disease Control and Prevention said Pfizer’s COVID vaccine — after just under two months — was 31% effective at preventing “symptomatic and asymptomatic” COVID in 5- to 11-year-olds. But how effective was the vaccine at four or six months?
03/21/22Pfizer CEO Pushes Yearly COVID Shots. Not So Fast, Experts Say. + More
The Defender’s COVID NewsWatch provides a roundup of the latest headlines related to the SARS CoV-2 virus, including its origins and COVID vaccines.